MeiraGTx Earns EMA PRIME Designation for Achromatopsia Gene Therapy Candidate

  • Post author:
  • Post category:BioPharma

A new gene therapy to treat a debilitating eye disorder is one step closer to regulatory approval in Europe.
Source: BioSpace